Dynamic Biotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Envestnet Asset Management Inc. raised its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE – Free Report) by 29.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,946 shares of the company’s stock after purchasing an additional 2,518 shares […]

Massachusetts Wealth Management acquired a new position in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE – Get Rating) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 9,115 shares of the company’s stock, valued at approximately $609,000. Massachusetts Wealth Management owned about 0.23% of Invesco Dynamic Biotechnology & […]

SignalPoint Asset Management LLC lessened its stake in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE – Get Rating) by 2.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 6,681 shares of the company’s stock after selling 177 shares during the period. SignalPoint Asset Management LLC […]

Commonwealth Equity Services LLC decreased its position in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE – Get Rating) by 1.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,662 shares of the company’s stock after selling 173 shares during the quarter. […]

Biotech ETFs was the biggest gainer last week.